Mathias Kroll M.b.a) Gaicd

Mathias Kroll, Ph.D., M.B.A. (IMD), GAICD, currently serves as Chief Business Officer at Cynata Therapeutics, focusing on corporate and business development, investor relations, and finance. Previously, Mathias held the position of Chief Commercial Officer at QIMR Berghofer Medical Research Institute, where strong commercial functions were built, significantly increasing marketing activity and commercialization income. Other notable roles include Chief Executive Officer at InProTher, Board Director at Abarceo Pharma, and Vice President at Bavarian Nordic, where impactful collaborations and innovative strategies were developed. Mathias's extensive experience spans various leadership positions in the healthcare sector, supported by a strong educational background in chemistry, biology, and viral immunology.